Authors
Latest:
Nuogen Pharma: Innovation in the fight against itchNuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Latest:
Practicing dermatology in the time of COVID-19Read one New York physician's insights on practice survival and patient care during the pandemic.
Latest:
CVS Removes Biosimilars From Drug ListOne notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.
Latest:
Expanding NP and PA Opportunities in Dermatology PracticeAt the inaugural Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, discussed how NPs and PAs can advance their professional growth by seizing opportunities to share their clinical experiences.
Latest:
The Role of Laser Treatments in Preventing Skin CancerPatricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.
Latest:
Think Globally to Combat AcneTake a world tour of the global game-changing advances and home-grown success strategies dermatologists in the United States and abroad are using to tackle the challenges of acne.
Latest:
Navigating Vitiligo Treatment: Decoding Pigmentation & Accessing CareRocco Serrao, MD, FAAD, addresses potential barriers to access and affordability of narrowband UVB phototherapy and topical medications for vitiligo treatment, while highlighting available resources to assist patients in overcoming these obstacles.
Latest:
Atopic Dermatitis Remains Controlled Even After Reduction of Dupilumab DosePatients with persistently controlled atopic dermatitis who had their doses reduced were able to maintain their low disease activity.
Latest:
Updates in Clinical Study of Patients of ColorMona Shahriari, MD, FAAD advocates for improving diversity in clinical imagery and trials to enhance trust in patients with skin of color.
Latest:
South Beach Symposium 2025: A Comprehensive Dermatology EventMedical and aesthetic dermatologists partner at SBS 2025 to bridge gaps between clinical care and cosmetic procedures.
Latest:
Saving the World Through Pharmaceutical InnovationThe COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.
Latest:
Doris Day, MD, Discusses Primary Axillary Hyperhidrosis and Brella SweatControl PatchBrella received FDA clearance last week for improving excessive underarm sweating.
Latest:
Navigating Skin Aging Across Diverse Tones: Tailored Approaches and Cultural AwarenessAn expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
Latest:
Offering an Insurance Package to Retain and Reward Employees: What Dermatologists Should KnowExplore various elements that can go into a comprehensive insurance benefits package for dermatology practice employees.
Latest:
CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and AgingTake a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.
Latest:
Improving Hyperhidrosis Treatment: The Role of IHhSDavid M. Pariser, MD, FACP, FAAD, secretary and a founding board member of the International Hyperhidrosis Society, discussed the latest in hyperhidrosis research and the organization’s commitment to helping clinicians treat the condition.
Latest:
Concluding Remarks: Systemic Treatment Considerations for Atopic Dermatitis in Patients of Childbearing PotentialLooking to the future of atopic dermatitis treatment, Drs Kiracofe and Murase offer concluding remarks on current unmet needs, the benefits of treatment guidelines, and the importance of treating itch in patients who are or may become pregnant.
Latest:
Key Takeaways for Adding Swift Wart Treatment to Your PracticeDustin Portela, DO, discuss how Swift microwave therapy can enhance patient care, generate referrals, and offer a promising revenue stream, while keeping pace with ongoing advancements in the technology.
Latest:
Outlining SCALE 2023 with Brian Biesman, MD, FACSAs co-director, Biesman is looking forward to all attendees being able to find medical and aesthetic sessions relevant to their education.
Latest:
Creating a Telehealth Experience For Postoperative AppointmentsLaura Rezac, MD and her colleagues evaluated a teledermatology postoperative follow-up model after Mohs Micrographic surgery.
Latest:
Jim Lee, MD, PhD, Reflects on New Research at AAD and Advances in Dermatology"It's an exciting time" in dermatology, said Lee, who reflects on late-breaker data and other research presented at the 2024 AAD Annual Meeting.
Latest:
ICYMI: FDA Greenlights Yesintek, Sixth Biosimilar to Stelara, for Psoriasis and Psoriatic ArthritisThe FDA recently approved Yesintek for treating psoriasis, psoriatic arthritis, and IBD, with a 2025 launch expected.
Latest:
My experience with surface radiotherapySuperficial radiation offers a newer, FDA-approved office-based option that is safe. Steven A. Davis, M.D., shares his experience using surface radiotherapy to treat his patients with non-melanoma skin cancer.
Latest:
Combining Surgical Precision With Immunological Innovation in Vitiligo TreatmentMaggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.
